White label – Pompe disease - ClinicalTrials.eu

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Not recruiting

2 1 1 1
Investigated Diseases:
- Portal hypertension
Investigated Drugs:
- Bi 685509
- Empagliflozin
+3
Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Small cell lung cancer extensive stage
Investigated Drugs:
+2
Study on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Not recruiting

3 1 1 1
Investigated Diseases:
- Hyperoxaluria
Investigated Drugs:
- Lumasiran
Study on the Effectiveness and Safety of BP1.7881 for Adults with Moderate-to-Severe Atopic Dermatitis

Not recruiting

2 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Bp1.7881A
Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

Not recruiting

3 1 1 1
Investigated Drugs:
+6
Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
- Tamoxifen
- Giredestrant
Study on Everolimus and Mycophenolate Mofetil for Improving COVID-19 Vaccine Response in Kidney Transplant Patients

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Teicoplanin Dosing for Patients with Sepsis: Comparing TDM-Optimized Dosing to Standard Care

Not recruiting

3 1 1 1
Investigated Diseases:
- Sepsis
Investigated Drugs:
- Teicoplanin
Study on BIA 28-6156 for Parkinson’s Disease in Patients with GBA1 Gene Variant

Not recruiting

2 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- 5,7-Dimethyl-N-((1R,4R)-4-(Pentyloxy)Cyclohexyl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies